Synageva BioPharma (GEVA)

37.84 -0.35  -0.92%  May 25, 11:00PM Go Pro
You must be signed in to use watchlists.
Sign In or Register
Watch this stock

Synageva BioPharma Current Ratio: 8.986

Get Interactive Chart for


of


Select a metric
 
Date range: to
<Embed Chart> Pro Save as Image Pro Data Export
Copy the code below and paste
into the embed destination.
  Done
Attention OK

GEVA Current Ratio Rankings

Overall 95th percentile 212 of 4373
Sector 88th percentile 60 of 503 in Healthcare
Industry 81st percentile 30 of 159 in Biotechnology

GEVA Current Ratio Range, Past 5 Years

Minimum 7.385 Jun 2008
Maximum 54.89 Mar 2011
Average 19.18

About Current Ratio

The current ratio measures a company's ability to pay short-term debts and other current liabilities (financial obligations lasting less than one year) by comparing current assets to current liabilities. Current assets are cash and any assets expected to be converted into cash within the next year. The ratio illustrates a company's ability to remain solvent.

A current ratio of 1 means that book value of current assets is exactly the same as book value of current liabilities. In general, investors look for a company with a current ratio of 2:1, meaning that it has twice as many current assets as current liabilities. A current ratio less than one indicates the company might have problems meeting short-term financial obligations. If the ratio is too high, the company may not be efficiently using its current assets or short term financing facilities.
Learn More

You may also be interested in these GEVA related companies

Display in Live Stream: Done
Options

GEVA News

Other relative strength names of interest: $abco $conn $fire $fnbn $geva $mdvn $mgam $omer $snak
about 10 days ago by flare9x
$GEVA Insider Sale: $1.5M of stock sold by Carsten Boess on May 16, 2012 http://stks.co/3tvv
about 11 days ago by MarketBrief
$GEVA filed latest Quarterly Report http://stks.co/3jqV
about 20 days ago by MarketBrief
Synageva BioPharma Falls 3%
Apr 23, 3:27PM Benzinga
$GEVA filed latest Annual Report http://stks.co/33Ia
about 67 days ago by MarketBrief
$GEVA filed latest Annual Report http://stks.co/31hx
about 68 days ago by MarketBrief
$GEVA High-tight flag pattern. Unfortunately not much liquidity.
about 87 days ago by BaselineAce
4 Rare Disease Stocks
Mar 01, 4:32AM
pretty decent PB in $ibb the last few days. Biotechs holding up: $celg $amgn $geva $alxn $idix $amln
about 97 days ago by Contrarius
RT @ChartSwingTrade $SZYM is a very interesting chart here/my second favorite after $GEVA
about 103 days ago by ivan_bg
Some stocks that stood out today: $VRSK $GEVA $ELOS $VRA $MELI
about 104 days ago by ivanhoff
Its all about the volume. Someone wanted into this thin one today. Watching for new highs here $GEVA http://chart.ly/77u7yi6
about 104 days ago by lasertrader
$PCYC and $GEVA .... maybe the next apple?
about 106 days ago by sundeeptrade
$GEVA my 36 bid alert hit today on this RARE BIRD PATTERN. The elusive HIGH TIGHT FLAG: http://stks.co/2NlD
about 106 days ago by TCMLLC
$GEVA is $36.100. I It is currently 0% above the actual breakout pivot. $GEVA is buy
about 106 days ago by sundeeptrade
$GEVA c&#39;mon need 70k volume for breakout!
about 106 days ago by sundeeptrade
$GEVA anyone? in 3 months might be in $70 range
about 106 days ago by sundeeptrade
I know rare diseases are hot. But $750M mkt cap for $GEVA Ph 1/2 is a bit rich. Though pipeline attractive to Big Pharma
about 126 days ago by exMBB
[$$] 13D Filings
Jan 21, 6:37AM
Charts showing &#39;Ants&#39; in their pants : $JAZZ $BVSN $INVN $GEVA $UAN $TAL
about 130 days ago by TCMLLC
$GEVA Insider Buy: $30.2M of stock bought by Thomas Tisch on January 10, 2012 http://stks.co/1uXk
about 137 days ago by MarketBrief
Going parabolic: Synageva Biopharma ($GEVA) zooming up from $10 Nov IPO low to $37.50 &amp; no sign of slowing down. Volume increasing, too.
about 138 days ago by DrKris
Sign of demand for stock is out there $SPY $ES_F, see deals for $VTR $GEVA $CHTP $RGLD $CMLP $SUI $DDR $CPT $TRNO $ARR
about 138 days ago by JFinDallas
$GEVA Insider Buy: $30.2M of stock bought by Thomas Tisch on January 10, 2012 http://stks.co/1tEX
about 138 days ago by MarketBrief
$GEVA Announces Pricing of Public Offering of Common Stock at $25.18/Share
about 145 days ago by Benzinga
$GEVA Announces $60 Million Proposed Public Offering of Common Stock
about 146 days ago by Benzinga
Synageva BioPharma falls 12.3%
Nov 17, 10:00AM FlyOnTheWall

Recent Quotes

Symbol Price Chg Chg % Market Cap
GEVA 37.84 -0.35 -0.92% 801.07M
GET 34.22 -0.28 -0.81% 1.661B
GES 27.11 +0.41 +1.54% 2.432B
GERN 1.42 +0.03 +2.16% 187.81M
GEOY 20.39 +1.29 +6.75% 453.47M
FVE 3.05 -0.03 -0.97% 146.10M
FVD 16.26 -0.02 -0.12%
FURX 19.10 +0.88 +4.83% 190.04M
FUR 10.30 -0.10 -0.96% 340.42M
FUND 6.26 +0.06 +0.97%
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close